Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Murder For Hire? What You Need To Know About Enochian Biosciences Co-Founder's Arrest

Published 25/05/2022, 22:17
Updated 25/05/2022, 23:11
© Reuters.  Murder For Hire? What You Need To Know About Enochian Biosciences Co-Founder's Arrest

© Reuters. Murder For Hire? What You Need To Know About Enochian Biosciences Co-Founder's Arrest

The co-founder of Enochian Biosciences Inc (NASDAQ: ENOB) was arrested Wednesday following a two-year investigation into a man who was kidnapped and found dead in January 2018.

What happened: Dr. Serhat Gumrukcu, co-founder of Enochian Biosciences, is being charged with conspiring to use interstate commerce facilities in the commission of murder-for-hire, which resulted in the death of Gregory Davis, a resident of Vermont.

Gumrucku, alongside another man, Berk Eratay, hired Jerry Banks to kidnap Davis from his home in Vermont on Jan. 6, 2018, according to the Department of Justice.

Davis was found dead in a snowbank several miles from his home the next day. While Banks has not been formally charged with the murder of Davis, it is alleged that Banks did, in fact, murder Davis.

If convicted of the federal grand jury charges against them, Gumrukcu and Eratay face mandatory life in prison or the death penalty.

Shares of the company’s stock plummeted 38.8% on the news.

A company update: The board of directors at Enochian provided an update following the arrest of the company's co-founder.

The incident occurred before the company's merger, and the company's rights to Gumrukcu's scientific discoveries are unchanged, Enochian said.

Gumruckcu has had no formal role in the company of late, according to Enochian. The company announced the appointment of Greg Alton, former interim CEO and general counsel of Gilead Sciences (NASDAQ: NASDAQ:GILD), as its lead independent board member.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.